Hoshi A | National Cancer Center Resarch Institute
スポンサーリンク
概要
関連著者
-
Hoshi A
National Cancer Center Resarch Institute
-
Hoshi Akio
国立がんセンター
-
Kuretani Kazuo
Pharmacology Division National Cancer Center Research Institute
-
Hoshi Akio
Pharmacology Division National Cancer Center Research Institute
-
Hoshi Akio
National Cancer Center Research Institute
-
Hoshi Akio
Pharmaceutical Development Laboratories Meiji Seika Kaisha Ltd. : Central Research Laboratories Meij
-
Ishiguro Masaji
Loboratory Of Chemistry For Natural Products Tokyo Institute Of Technology
-
Iigo Masaaki
Pharmacology Division National Cancer Center Research Institute
-
HOSHI Akio
National Cancer Center Resarch Institute
-
Iigo M
National Cancer Res. Inst. Tokyo
-
Iigo Masaaki
Cancer Prevention Basic Res. Project National Cancer Center Res. Inst.
-
Iigo Masaaki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
INOMATA Motoko
Pharmacology Division, National Cancer Center Research Institute
-
Inomata Motoko
Pharmacology Division National Cancer Center Research Institute
-
Inomata Motoko
National Cancer Center Research Institute
-
KURETANI KAZUO
National Cancer Center Research Institute
-
YOSHIDA MITSUZI
National Cancer Center Research Institute
-
Yoshida Mitsuzi
Pharmacology Division National Cancer Center Research Institute
-
Kanzawa Fumihiko
Pharmacology:pathology Division National Cancer Center Research Institute:surgery Division:departmen
-
Kanzawa Fumihiko
Pharmacology Division National Cancer Center Research Institute
-
IIGO MASAAKI
National Cancer Center Research Institute
-
Iigo Masaaki
National Cancer Center Resarch Institute
-
ANDO NAOKO
Pharmacology Division, National Cancer Center Research Institute
-
Ando Naoko
Pharmacology Division National Cancer Center Research Institute
-
FUKUOKA FUMIKO
National Cancer Center Research Institute
-
SANEYOSHI MINEO
Faculty of Pharmaceutical Sciences, Hokkaido University
-
Saneyoshi Mineo
Faculty Of Pharmaceutical Sciences Hokkaido University
-
NAKAMURA ASAKO
Pharmacology Division, National Cancer Center Research Institute
-
Nakamura Asako
Pharmacology Division National Cancer Center Research Institute
-
Ozaki S
Faculty Of Pharmaceutical Sciences Osaka University
-
HOSHIKO TOMONORI
Faculty of Engineering, Ehime University
-
MORI HARUKI
Research Center, Mitsui Toatsu Chemicals
-
Watanabe Y
Department Of Molecular Biopharmacy And Genetics Graduate School Of Pharmaceutical Sciences Tohoku U
-
OZAKI Shoichiro
Department of Chemistry, Shandong University
-
KONG Xiangzheng
Department of Chemistry, Shandong University
-
WATANABE Yutaka
Faculty of Engineering, Ehime University
-
KOGA Toshikazu
Faculty of Engineering, Ehime University
-
OGASAWARA Tomio
Faculty of Engineering, Ehime University
-
TAKIZAWA Tsuneharu
Faculty of Engineering, Ehime University
-
FUJISAWA Hiroshi
Faculty of Engineering, Ehime University
-
OZAKI SHOICHIRO
Faculty of Engineering, Ehime University
-
NAGASE TOSHIO
Faculty of Engineering, Ehime University
-
TAMAI HIROFUMI
Faculty of Engineering, Ehime University
-
YOSHIDA MITSUZI
Pharmacology Division, National Cancer Center Research Institute
-
TOKUZEN REIKO
Pharmacology Division, National Cancer Center Research Institute
-
FUKUKAWA KIYOFUMI
Faculty of Pharmaceutical Sciences, Hokkaido University
-
UEDA TOHRU
Faculty of Pharmaceutical Sciences, Hokkaido University
-
星子 知範
Faculty of Engineering, Ehime University
-
ANDO NAOKO
National Cancer Center Research Institute
-
IKEKAWA NOBUO
Loboratory of Chemistry for Natural Products, Tokyo Institute of Technology
-
星子 知範
Eisai Tsukuba Research Laboratories
-
Hoshiko Tomonori
Faculty Of Engineering Ehime University
-
Watanabe Yoshifumi
Department Of Biomolecular Engineering Tokyo Institute Of Technology
-
Mori H
Kumamoto Univ. Kumamoto Jpn
-
Ikekawa Nobuo
Loboratory Of Chemistry For Natural Products Tokyo Institute Of Technology
-
Tokuzen R
National Cancer Center Research Inst. Tokyo Jpn
-
Nagase T
Faculty Of Engineering Ehime University
-
Koga Toshikazu
Faculty Of Engineering Ehime University
-
Tamai Hirofumi
Faculty Of Engineering Ehime University
-
Ozaki Shoichiro
Department Of Applied Chemistry Faculty Of Engineering Ehime University
-
Ogasawara T
Faculty Of Engineering Ehime University
-
Ueda T
Process Development Center Sharp Corporation
-
Tokuzen Reiko
Pharmacology Division National Cancer Center Research Institute
-
Fujisawa H
Faculty Of Engineering Ehime University
-
Fukukawa K
Toyo Jozo Co. Ltd. Shizuoka Jpn
-
Kong Xiangzheng
Department Of Chemistry Shandong University
-
Takizawa T
Faculty Of Engineering Ehime University
-
Ueda Tohru
Faculty Of Bioresource Sciences Akita Prefectural University
-
Watanabe Yutaka
Faculty Of Agriculture Hokkaido University
-
Watanabe Yoshihiko
Department of Molecular Biopharmacy and Genetics, Graduate School of Pharmaceutical Sciences, Tohoku University
-
YOSHIDA Mitsuzi
Pharmaceutical Development Laboratories, Meiji Seika Kaisha, Ltd. : Central Research Laboratories, Meiji Seika Kaisha, Ltd. : National Cancer Center Research Institute.
著作論文
- 5-Fluorouracil Derivatives. XXII. Synthesis and Antitumor Activities of 1-Carbamoyl-5-fluorouracils
- 5-Fluorouracil Derivatives. XII. : Synthesis and Antitumor Activity of α-Alkylthiomethyl-, α-Alkylsulfinylmethyl-, α-Alkylsulfonylmethyl-, and α-Acylthiomethyl-5-fluorouracils(Medeicinal Chemistry,Chemical)
- ANTITUMOR ACTIVITY OF 1-ACYLOXYMETHYL DERIVATIVES OF 5-FLUOROURACIL AGAINST L1210 LEUKEMIA
- ANTITUMOR ACTIVITY OF ALKYLDISULFIDE DERIVATIVES OF 6-MERCAPTOPURINES AGAINST L-1210 LEUKEMIA
- ANTITUMOR ACTIVITY OF 1-ALKOXYCARBONYLALKYLCAR-BAMOYL-5-FLUOROURACIL DERIVATIVES BY ORAL ADMINISTRATION
- STRUCTURE-ANTITUMOR ACTIVITY RELATIONSHIP OF PURIN-6-YL ALKYL DISULFIDES
- ANTITUMOR ACTIVITY OF DERIVATIVES OF NEPLANOCIN A IN VIVO AND IN VITRO
- ISOLATION AND CHARACTERIZATION OF THE MURINE LYMPHOMA L5178Y CELL LINE HIGHLY RESISTANT TO 5-FLUOROURACIL
- THE DIFFERENCE IN MECHANISM OF ACTION OF 5-FLUOROURACIL AND ITS NUCLEOSIDES IN L5178Y CELLS
- IMPROVEMENT OF THERAPEUTIC EFFECT OF 5-FLUOROURACIL BY OROTIC ACID
- EFFECT OF PYRIMIDINES, PURINES AND THEIR NUCLEOSIDES ON ANTITUMOR ACTIVITY OF 5-FLUOROURACIL AGAINST L-1210 LEUKEMIA
- EXCRETION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN URINE OF MICE
- ANTITUMOR ACTIVITY OF METABOLITES OF 1-HEXYLCAR-BAMOYL-5-FLUOROURACIL AND RELATED COMPOUNDS AGAINST L1210 LEUKEMIA IN VIVO AND L5178Y LYMPHOMA CELLS IN VITRO
- RELATIONSHIP BETWEEN CHEMICAL STRUCTURE AND ANTITUMOR ACTIVITY OF WITHAFERIN A ANALOGUES
- DISTRIBUTION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL BY ORAL ADMINISTRATION IN MICE